Two Sigma Investments’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Two Sigma Investments's NVS Position: Q1 2026 in Review
Two Sigma Investments reduced its Novartis (NVS) stake by 8% in Q1 2026, selling an estimated $368K and leaving 27,528 shares worth $4.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2126.
Two Sigma Investments first reported a position in NVS in Q2 2013 and has held it in 35 quarters since. The position peaked at $170M in Q1 2022. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Two Sigma Investments held 27,528 shares of Novartis worth $4.2M as of Q1 2026.
- Two Sigma Investments sold 2,400 Novartis shares in Q1 2026, an estimated $368K.
- Novartis made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2126 holding.
- Two Sigma Investments first reported a position in Novartis in Q2 2013 and has held it in 35 quarters since.
- Two Sigma Investments's Novartis position peaked at $170M in Q1 2022.
- 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.